Ushbu ish iqtibos qilgan ishlar

19 ta ish

Ish: Design, synthesis, biological evaluation of a new tricyclicthiazolopy‐rimidinone derivatives as acetylcholinesterase inhibitors

Design, synthesis, in vitro evaluation of a new pyrrolo[1,2‐a]thiazolo[5,4‐d]pyrimidinone derivatives as cholinesterase inhibitors against Alzheimer's disease
Yan Zeng, Lifei Nie, Liu Liu +6
MaqolaCholinesterase and Neurodegenerative DiseasesJournal of Heterocyclic Chemistry202217 iqtibos
ABI
Diversity-oriented synthesis of amide derivatives of tricyclic thieno[2,3- d ]pyrimidin-4(3 H )-ones and evaluation of their influence on melanin synthesis in murine B16 cells
Li Fei Nie, Guozheng Huang, Khurshed Bozorov +4
MaqolaSynthesis of Organic CompoundsHeterocyclic Communications201815 iqtibos
ABI
<scp>2‐substituted</scp> tricyclic oxazolo[5,4‐d]pyrimidine library: Design, synthesis, and cytotoxicity activity
Yan Zeng, Lifei Nie, Khurshed Bozorov +4
MaqolaQuinazolinone synthesis and applicationsJournal of Heterocyclic Chemistry202111 iqtibos
ABI
Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation
Fang Ma, Hongtao Du
Maqola20176 iqtibos
ABI
Discovery of deoxyvasicinone derivatives as inhibitors of NEDD8-activating enzyme
Hai‐Jing Zhong, Ka‐Ho Leung, Sheng Lin +5
Maqola20145 iqtibos
ABI
Novel Deoxyvasicinone–Donepezil Hybrids as Potential Multitarget Drug Candidates for Alzheimer’s Disease
Hongtao Du, Xinlian Liu, Jusen Xie +1
Maqola20195 iqtibos
ABI
Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with ‘inverted’ binding mode
Fouad H. Darras, Sarah Wehle, Guozheng Huang +2
Maqola20143 iqtibos
ABI
Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease
Muriel Noetzli, Chin B. Eap
Sharh maqola20133 iqtibos
ABI
Pharmacogenetic Considerations in the Treatment of Alzheimer’s Disease
Ramón Cacabelos, Clara Torrellas, Óscar Teijido +1
Sharh maqola20163 iqtibos
ABI
Nootropic and Anti-Alzheimer’s Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer’s Neuropathology
Md. Sahab Uddin, Abdullah Al Mamun, Md. Tanvir Kabir +4
Sharh maqola20183 iqtibos
ABI
A review on cholinesterase inhibitors for Alzheimer’s disease
Preet Anand, Baldev Singh
Sharh maqola20132 iqtibos
ABI
Peroxide-Mediated Oxidative Radical Cyclization to the Quinazolinone System: Efficient Syntheses of Deoxyvasicinone, Mackinazolinone and (±)-Leucomidine C
Luis D. Miranda, Jazmín García-Ramírez
Maqola20202 iqtibos
ABI
Crystal structure, Hirshfeld surface analysis and energy framework study of 6-formyl-7,8,9,11-tetrahydro-5H-pyrido[2,1-b]quinazolin-11-one
Akmaljon Tojiboev, Sherzod Zhurakulov, Валентина И. Виноградова +2
MaqolaQuinazolinone synthesis and applicationsActa Crystallographica Section E Crystallographic Communications20202 iqtibos
ABI
Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice
Elisabet Viayna, Nicolas Coquelle, Monika Cieslikiewicz‐Bouet +23
Maqola20202 iqtibos
ABI
Discovery of Novel Tacrine–Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer’s Disease
Hong Yao, Giuseppe Uras, Pengfei Zhang +11
Maqola20212 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI
Sarlavhasiz
Boshqa1 iqtibos
ABI

Ushbu ish iqtibos qilgan ishlar

Design, synthesis, in vitro evaluation of a new pyrrolo[1,2‐<i>a</i>]thiazolo[5,4‐<i>d</i>]pyrimidinone derivatives as cholinesterase inhibitors against Alzheimer's disease

Diversity-oriented synthesis of amide derivatives of tricyclic thieno[2,3- <i>d</i> ]pyrimidin-4(3 <i>H</i> )-ones and evaluation of their influence on melanin synthesis in murine B16 cells

<scp>2‐substituted</scp> tricyclic oxazolo[5,4‐<i>d</i>]pyrimidine library: Design, synthesis, and cytotoxicity activity

Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation

Discovery of deoxyvasicinone derivatives as inhibitors of NEDD8-activating enzyme

Novel Deoxyvasicinone–Donepezil Hybrids as Potential Multitarget Drug Candidates for Alzheimer’s Disease

Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with ‘inverted’ binding mode

Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease

Pharmacogenetic Considerations in the Treatment of Alzheimer’s Disease

Nootropic and Anti-Alzheimer’s Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer’s Neuropathology

A review on cholinesterase inhibitors for Alzheimer’s disease

Peroxide-Mediated Oxidative Radical Cyclization to the Quinazolinone System: Efficient Syntheses of Deoxyvasicinone, Mackinazolinone and (±)-Leucomidine C

Crystal structure, Hirshfeld surface analysis and energy framework study of 6-formyl-7,8,9,11-tetrahydro-5<i>H</i>-pyrido[2,1-<i>b</i>]quinazolin-11-one

Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice

Discovery of Novel Tacrine–Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer’s Disease

Sarlavhasiz

Sarlavhasiz

Sarlavhasiz

Sarlavhasiz